Altimmune Insider Trades

+0.34 (+2.63 %)
(As of 05/7/2021 03:59 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume13,758 shs
Average Volume1.47 million shs
Market Capitalization$492.98 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Altimmune (NASDAQ:ALT) Insider Buying and Selling Activity

Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $19,628,833.28
Insider Selling (Last 12 Months): $1,041,774.68

Insider Buying and Selling by Quarter

Altimmune (NASDAQ ALT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2021Philip HodgesDirectorSell6,000$16.08$96,480.008,731  
12/10/2020Klaus SchaferDirectorBuy2,000$11.99$23,980.008,900  
11/30/2020Philip HodgesDirectorSell2,500$12.00$30,000.0014,731  
11/12/2020Klaus SchaferDirectorSell10,150$9.91$100,586.506,900  
6/15/2020Venrock Healthcare Capital ParMajor ShareholderBuy1,500,000$7.54$11,310,000.00  
5/28/2020Venrock Healthcare Capital ParMajor ShareholderBuy201,474$8.72$1,756,853.28  
5/26/2020Venrock Healthcare Capital ParMajor ShareholderBuy700,000$9.34$6,538,000.00  
5/14/2020Pharmaceutical Holdin VelocityMajor ShareholderSell169,378$4.81$814,708.18  
9/5/2019Vipin K GargCEOBuy20,000$2.10$42,000.00342,907  
10/9/2018Wayne PisanoDirectorBuy2,000$4.59$9,180.002,000  
5/25/2018William EnrightInsiderBuy1,300$0.51$663.00365,839  
12/29/2017Derace L SchafferDirectorBuy97,410$1.92$187,027.20  
12/28/2017Derace L SchafferDirectorBuy58,711$1.92$112,725.12550,754  
12/27/2017Derace L SchafferDirectorBuy147,130$1.76$258,948.80362,895  
12/22/2017Derace L SchafferDirectorBuy17,982$1.61$28,951.02362,895  
12/7/2017Derace L SchafferDirectorBuy23,745$1.78$42,266.10337,274  
12/5/2017Derace L SchafferDirectorBuy26,010$1.79$46,557.90300,373  
11/30/2017Derace L SchafferDirectorBuy33,315$1.91$63,631.65274,238  
11/27/2017Derace L SchafferDirectorBuy21,808$2.03$44,270.24245,296  
11/24/2017Derace L SchafferDirectorBuy6,505$2.02$13,140.10245,296  
11/22/2017Derace L SchafferDirectorBuy5,261$2.10$11,048.10245,296  
11/20/2017Derace L SchafferDirectorBuy4,800$2.07$9,936.00227,999  
11/17/2017Derace L SchafferDirectorBuy6,295$2.12$13,345.40227,999  
8/25/2017Derace L SchafferDirectorBuy67,326$2.25$151,483.50171,704  
8/23/2017Derace L SchafferDirectorBuy50,000$2.21$110,500.00105,068  
6/2/2017John GillDirectorBuy1,000$4.34$4,340.0083,224  
(Data available from 1/1/2013 forward)
This page was last updated on 5/7/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.